111 related articles for article (PubMed ID: 26741854)
1. Combating P-glycoprotein-mediated multidrug resistance with 10-O-phenyl dihydroartemisinin ethers in MCF-7 cells.
Zhong H; Zhao X; Zuo Z; Sun J; Yao Y; Wang T; Liu D; Zhao L
Eur J Med Chem; 2016 Jan; 108():720-729. PubMed ID: 26741854
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin.
Luan S; Zhong H; Zhao X; Yang J; Jing Y; Liu D; Zhao L
Eur J Med Chem; 2017 Dec; 141():584-595. PubMed ID: 29102180
[TBL] [Abstract][Full Text] [Related]
3. Paris saponin VII from trillium tschonoskii reverses multidrug resistance of adriamycin-resistant MCF-7/ADR cells via P-glycoprotein inhibition and apoptosis augmentation.
Li Y; Fan L; Sun Y; Miao X; Zhang F; Meng J; Han J; Zhang D; Zhang R; Yue Z; Mei Q
J Ethnopharmacol; 2014 Jul; 154(3):728-34. PubMed ID: 24818584
[TBL] [Abstract][Full Text] [Related]
4. Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index.
Bai J; Wang RH; Qiao Y; Wang A; Fang CJ
Drug Des Devel Ther; 2017; 11():2227-2237. PubMed ID: 28814831
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of a novel artesunate-podophyllotoxin conjugate as anticancer agent.
Zhang L; Chen F; Zhang Z; Chen Y; Wang J
Bioorg Med Chem Lett; 2016 Jan; 26(1):38-42. PubMed ID: 26615886
[TBL] [Abstract][Full Text] [Related]
6. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
[TBL] [Abstract][Full Text] [Related]
7. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
Cai P; Lu P; Sharom FJ; Fang WS
Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
[TBL] [Abstract][Full Text] [Related]
8. Reversal of P-glycoprotein-mediated multidrug resistance in MCF-7/Adr cancer cells by sesquiterpene coumarins.
Kasaian J; Mosaffa F; Behravan J; Masullo M; Piacente S; Ghandadi M; Iranshahi M
Fitoterapia; 2015 Jun; 103():149-54. PubMed ID: 25843566
[TBL] [Abstract][Full Text] [Related]
9. O
Li Q; Zou P; Sun J; Chen L
Eur J Med Chem; 2018 Jan; 143():732-744. PubMed ID: 29220794
[TBL] [Abstract][Full Text] [Related]
10. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y
J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
[TBL] [Abstract][Full Text] [Related]
11. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
Li F; Fan J; Wu Z; Liu RY; Guo L; Dong Z; Wang Z
Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360
[TBL] [Abstract][Full Text] [Related]
12. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
13. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
14. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.
De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS
Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517
[TBL] [Abstract][Full Text] [Related]
15. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
[TBL] [Abstract][Full Text] [Related]
16. Effects of Psoralen as an Anti-tumor Agent in Human Breast Cancer MCF-7/ADR Cells.
Wang X; Cheng K; Han Y; Zhang G; Dong J; Cui Y; Yang Z
Biol Pharm Bull; 2016 May; 39(5):815-22. PubMed ID: 26902225
[TBL] [Abstract][Full Text] [Related]
17. A novel compound RY10-4 downregulates P-glycoprotein expression and reverses multidrug-resistant phenotype in human breast cancer MCF-7/ADR cells.
Xue P; Yang X; Liu Y; Xiong C; Ruan J
Biomed Pharmacother; 2014 Oct; 68(8):1049-56. PubMed ID: 25455158
[TBL] [Abstract][Full Text] [Related]
18. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly.
Chen H; Li S; Wang S; Li W; Bao N; Ai W
Bioorg Med Chem Lett; 2018 Aug; 28(14):2490-2492. PubMed ID: 29903663
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of nitric oxide-releasing DDB derivatives as potential Pgp-mediated MDR reversal agents in MCF-7/Adr cells.
Tang X; Gu X; Ai H; Wang G; Peng H; Lai Y; Zhang Y
Bioorg Med Chem Lett; 2012 Jan; 22(2):801-5. PubMed ID: 22209486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]